Commercial Products and CNS Pipeline

Neos Therapeutics develops, manufactures and commercializes innovative CNS products using its microparticle delivery technology to help meet the needs of patients and their families. Our innovative technology enables the development of complex modified-release therapies and is used in our three approved ADHD products, generic tussionex and our pipeline candidate.